Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 8/20 | 0.39 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.35 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | TNF | P01375 | 1/20 | 0.34 |
| ▸ | USP7 | Q93009 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19992609 | 0.83 | DYRK3 (0.38) | TRPA1DYRK3CCNA2CDK2DYRK1A | |
| SCHEMBL22256394 | 0.82 | TRPA1 (0.40) | TRPA1DYRK3CCNA2CDK2DYRK1A | |
| SCHEMBL22256396 | 0.77 | KDM4E (0.50) | DYRK3CCNA2CDK2DYRK1ADYRK2 | |
| SCHEMBL19992566 | 0.70 | TRPA1 (0.35) | TRPA1KDM4EALDH1A1USP7 | |
| SCHEMBL19992607 | 0.70 | USP7 (0.41) | TRPA1KDM4EALDH1A1USP7 | |
| SCHEMBL19992608 | 0.70 | TRPA1 (0.40) | TRPA1DYRK3CCNA2CDK2DYRK1A | |
| SCHEMBL25350169 | 0.70 | TRPA1 (0.35) | TRPA1KDM4ERXFP1 | |
| SCHEMBL28074599 | 0.68 | TSHR (0.43) | KDM4ETRPV1 | |
| SCHEMBL23131449 | 0.66 | TRPA1 (0.36) | TRPA1KDM4EALDH1A1RXFP1 | |
| SCHEMBL17664492 | 0.66 | FEN1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11084815-B2 | Heterocyclic compound and harmful arthropod controlling agent containing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-08-10 | — | — | US | disclosed |
| US-11040971-B2 | — | — | 2021-06-22 | — | — | US | disclosed |
| US-20200231587-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD CONTROLLING AGENT CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11040971-B2 | — | C1QBP, C5, C3AR1 | TRPA1 602/4885DYRK3 4136/4885CCNA2 517/4885 |
| US-20200231587-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD CONTROLLING AGENT CONTAINING SAME | C5, C3AR1, C9 | TRPA1 278/4885DYRK3 4176/4885CCNA2 323/4885 |
| US-11084815-B2 | Heterocyclic compound and harmful arthropod controlling agent containing same | C5, C3AR1, C9 | TRPA1 278/4885DYRK3 4176/4885CCNA2 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.